Oscar Health, Inc.
Oscar Health, Inc.（OSCR）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
oscr · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Hold
11 位分析师
共识
评级分布
12 个月目标价
High
$30.00
Consensus
$20.80
-22.4% upside
Low
$16.00
Median: $20 · Last Close: $26.81
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$20.80
-22.4% upside
High Target
$30
11.9%
Low Target
$16
-40.3%
Current Price
$26.81
as of today
Based on analyst price targets, the OSCR stock price prediction for the next 12 months ranges from $16 to $30. The consensus OSCR price forecast of $20.80 implies -22.4% upside from the current price of $26.81.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.03 | ↑ 0.83% |
1-day model range: $26.77–$27.3. Peak: $27.3 (+0.83%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $32 | +17.6% |
| 2028 | $35 | +30.0% |
| 2029 | $37 | +38.2% |
| 2030 | $38 | +43.4% |
| 2031 | — | +46.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OSCR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-05-07 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-05-07 | UBS | Maintains | Neutral→Neutral |
| 2026-05-07 | Baird | Maintains | Neutral→Neutral |
| 2026-04-20 | Jefferies | Upgrade ↑ | Underperform→Hold |
| 2026-01-09 | UBS | Upgrade ↑ | Sell→Neutral |
| 2026-01-05 | Barclays | Upgrade ↑ | Underweight→Equal Weight |
| 2025-11-26 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2025-11-13 | Wells Fargo | Maintains | Underweight→Underweight |
| 2025-11-10 | Barclays | Maintains | Underweight→Underweight |
Wall Street analysts have recently issued updated ratings on Oscar Health, Inc. (OSCR) stock. Of the recent 66 rating actions, 8 were upgrades and 10 were downgrades. 11 analysts currently cover OSCR.
分析师推荐趋势
OSCR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$18.5B
↓ 16.5% YoY
Revenue Next Year
$19.9B
↑ 7.4% YoY
EPS This Year
$0.90
EPS Next Year
$1.33
↑ 48.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast OSCR EPS of $0.90 for the current fiscal year, based on estimates from 6 analysts. The OSCR revenue forecast is $18.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
OSCR 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。OSCR 的共识目标价为 $20.80（-22.4% 上行空间），分析师共识为 Hold。
OSCR 的短期预测（明日）为 $27.03（+0.83%）。 OSCR 对 2027 年的股价预测均值为 $32。 OSCR 对 2030 年的预测区间为 $34–$43。
Oscar Health, Inc. 在 NYSE 上市，代码 OSCR。OSCR 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 18% 对应 Hold 共识。
常见问题
OSCR 预测 · 8 个问题根据 11 位华尔街分析师，OSCR 的 12 个月平均目标价为 $20.80，最高 $30.00、最低 $16.00。若有图表，中位目标价可在上方查看。相对当前价 $26.81，隐含约 -22.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.